Co-Diagnostics Confirms Flu Test Performance Against This Season’s H3N2 Strain
In silico analysis of 3,900 influenza sequences shows comparable sensitivity for the test against the subclade K variant currently circulating.
Read MorePosted by CLP Edit Staff | Dec 17, 2025 | Flu & Respiratory Infections |
In silico analysis of 3,900 influenza sequences shows comparable sensitivity for the test against the subclade K variant currently circulating.
Read MorePosted by CLP Edit Staff | Dec 17, 2025 | Molecular Diagnostic Analyzers |
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
Read MorePosted by Alyx Arnett | Dec 17, 2025 | Diagnostic Technologies |
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Read MorePosted by CLP Edit Staff | Dec 10, 2025 | Infectious Diseases |
The rapid PCR test delivers results up to 75% faster than other point-of-care HCV diagnostics, enabling same-day treatment initiation.
Read MorePosted by CLP Edit Staff | Dec 9, 2025 | Information Technology |
The presentation introduces the Co-Dx PCR platform and smartphone interface and discusses how Co-Dx is harnessing AI to minimize user error and improve outcomes in real-time point-of-care testing.
Read More